Psychotropic drugs and paediatrics: a critical need for more clinical trials

Many children in the USA are prescribed psychotropic drugs that have not been fully investigated in paediatric clinical trials. The common practice of prescribing psychotropic drugs off-label poses unknown and potentially serious short- and long-term consequences for these children. This paper brief...

Full description

Saved in:  
Bibliographic Details
Authors: Tishler, L. (Author) ; Reiss, S. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2012
In: Journal of medical ethics
Year: 2012, Volume: 38, Issue: 4, Pages: 250-252
Online Access: Volltext (JSTOR)
Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 1816143383
003 DE-627
005 20230427161304.0
007 cr uuu---uuuuu
008 220908s2012 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2011-100003  |2 doi 
035 |a (DE-627)1816143383 
035 |a (DE-599)KXP1816143383 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Tishler, L.  |e VerfasserIn  |4 aut 
245 1 0 |a Psychotropic drugs and paediatrics: a critical need for more clinical trials 
264 1 |c 2012 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Many children in the USA are prescribed psychotropic drugs that have not been fully investigated in paediatric clinical trials. The common practice of prescribing psychotropic drugs off-label poses unknown and potentially serious short- and long-term consequences for these children. This paper briefly reviews the factors associated with the lack of paediatric clinical trials. We advocate a shift toward increasing paediatric trials with psychotropic drugs through a combination of adequate safety controls, additional reimbursement/compensation, a more organised and large-scale effort to collate results and outcomes across researchers and studies and additional public education about the importance of this research. In addition, we encourage the re-examination of the ethical standards for children's participation in phase 1 clinical trials as well as argue for longitudinal developmental studies on children who are prescribed off-label psychotropic drugs. 
700 1 |a Reiss, S.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 38(2012), 4, Seite 250-252  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:38  |g year:2012  |g number:4  |g pages:250-252 
856 |3 Volltext  |u http://www.jstor.org/stable/23215473  |x JSTOR 
856 4 0 |u https://doi.org/10.1136/medethics-2011-100003  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/38/4/250.abstract  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
936 u w |d 38  |j 2012  |e 4  |h 250-252 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185597274 
LOK |0 003 DE-627 
LOK |0 004 1816143383 
LOK |0 005 20220908053553 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-03#BADF8F369EA03434234605BE31A7D446049E6950 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/23215473 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1  |b inherited from superior work 
ORI |a SA-MARC-ixtheoa001.raw